In addition, the mutation of the phosphorylation site of signaling transduction protein STK38L could ablate the kinase activity and block the activation, promoting cancer cell proliferation and destructing core pathway signaling transduction in the transforming early-stage thyroid cancer cells [29]. The gene discussed is STK38L; the disease is thyroid cancer.